Tag: Superficial vein thrombosis
SVT patients bear “significant risk” of thromboembolic complications at three months,...
Despite a high rate of initial anticoagulation, patients with isolated superficial vein thrombosis (SVT) are at risk of thromboembolic complications—including recurrent or extended SVT...
A look at new preliminary guidelines for superficial vein thrombosis
At the European Society of Vascular Surgery annual meeting (ESVS 2019; 24-27 September, Hamburg, Germany), preliminary venous thrombosis guidelines were presented for the first...
Current aspects in the management of superficial vein thrombosis
Superficial vein thrombosis is not a rare disease, with an incidence of 0.64 in 1,000 annually.1 The POST, OPTIMEV and STEPH studies have shown...
Treatment of superficial vein thrombosis with intermediate doses of tinzaparin
Superficial vein thrombosis (SVT) is a common disease affecting 3–11% of the general population, while in patients with varicose veins the incidence of SVT...